Renatus Tactical Adds Lauren Selig to Board, Curing Nasdaq Non-Compliance After Director Exit
RTAC is trading near its 52-week low of $10.26 (2.1% above the low).
Summary
On July 21, 2026, Renatus Tactical Acquisition Corp I appointed Lauren Selig to its board, curing the Nasdaq non-compliance triggered by a director's resignation in June. The move restores board committee composition and removes a near-term delisting risk.
Key Events · Executive and Board Changes · RTAC
-
Director Appointment Resolves Nasdaq Non-Compliance
Effective July 21, 2026, Lauren Selig was appointed as a director, filling the vacancy left by Matan Fattal's June 9 resignation that had caused a Nasdaq listing rule violation.
-
Board Committees Restored
Selig joins the Audit, Compensation, and Nominating and Corporate Governance Committees, restoring the board's required committee composition.
-
Sponsor Compensates New Director with 50,000 Class B Shares
As compensation, the sponsor, International SPAC Management Group I LLC, will transfer 50,000 Class B ordinary shares to Selig, aligning her interests with shareholders without a cash cost to the company.
-
Immediate Delisting Risk Removed
The appointment cures the Nasdaq non-compliance triggered by the prior director resignation, removing a near-term delisting threat for the SPAC.
Analysis · RTAC · Real Estate & Construction
Filling the board seat vacated by Matan Fattal's June 9 resignation, the appointment of Lauren Selig resolves a Nasdaq listing rule violation. Her addition to the Audit, Compensation, and Nominating Committees restores the board's required committee composition and eliminates an immediate delisting threat. To align her interests with shareholders, the sponsor is transferring 50,000 Class B shares as compensation. For a SPAC already under going-concern pressure, this governance fix is critical.
At the time of this filing, RTAC was trading at $10.48 on NASDAQ in the Real Estate & Construction sector, with a market capitalization of approximately $326.6M. The 52-week trading range was $10.26 to $12.20. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.